Cambridge Institute of Therapeutic Immunology & Infectious DiseaseWelcome to CITIID
The Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) was established by the Department of Medicine to support both fundamental and translational research on human disease.
We house around 250 scientists working within 25 research groups. Our work focusses on understanding the pathogenesis and improving the management of immune-related disorders and transforming our understanding of how the infectious agents interact with humans.
CITIID transforms immunity and infection research in Cambridge by providing researchers with advanced facilities that are in close proximity and enable them to optimise their work on human immune, inflammatory and infectious diseases. By bringing together its clinical capabilities and key industry partners, CITIID is also well-placed to drive therapeutic breakthroughs, improve patient outcomes and advance population health both in the UK and abroad.
;
Exciting Nature Immunology publication led by @HessLab in developing an online tool for predicting recovery from COVID-19.
@NIHRBioResource @h_ruffieux @MRC_BSU @gbantug2000
A patient-centric modelling framework captures recovery from SARS-CoV-2 infection – Department of Medicine
An international team of scientists has developed an online tool for predicting recovery from COVID-19, based on an …
www.med.cam.ac.uk
Congratulations @Jmtarkin & @DavenportLab
developing a new method diagnosing and monitoring large vessel vasculitis LVV: https://caths.cam.ac.uk/LVV
@hfj22 @Meri421_cam @TheBHF
Around a half of people on common antidepressants report emotional ‘blunting’ – feeling emotionally dull and no longer finding things as pleasurable as they used to.
Now, scientists @BJSahakian @DrCLangley have worked out why this might be the case 👇
Scientists explain emotional ‘blunting’ caused by common
According to the NHS, more than 8.3 million patients in England received an antidepressant drug in 2021/22. A wide…
bit.ly
Dr Meritxell Nus presents her teams work ‘Targeting the gut microbiota-adaptive immune response axis to modulate atherosclerosis’ at the next BHF Live and Ticking online event. Register online: https://www.bhf.org.uk/what-we-do/in-your-area/public-engagement-events/live-and-ticking
#CambridgeCardiovascular
https://www.cardiovascular.cam.ac.uk/directory/meritxell-nus
[1 of 2]
Interested in promoting your research and engage with the public?
Conducting research broadly related to women’s health?👩🏻⚕️🤰🏽🧬🔬
If so, we’d love to give you the opportunity to share your work via our platform!
#education #science #academia #publicengagement #WHUM
![Image for the Tweet beginning: [1 of 2]
Interested in promoting](https://pbs.twimg.com/media/FizxTNxXoAEz4X9.jpg)
